Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis

Med J Aust. 2013 Apr 1;198(6):331-3. doi: 10.5694/mja12.11003.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Diagnosis, Differential
  • Female
  • Humans
  • Leishmaniasis, Visceral / chemically induced*
  • Leishmaniasis, Visceral / diagnosis

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab